North American Veterinary Licensing Examination (NAVLE) Practice Test

Administering desmopressin acetate is clinically significant in cases of elevated buccal mucosal bleeding time primarily because it stimulates the release of von Willebrand factor from endothelial cells. Von Willebrand factor plays a crucial role in the coagulation process, particularly in the initial stages of hemostasis. It facilitates platelet adhesion to sites of vascular injury and also stabilizes factor VIII, an important clotting protein.

In conditions such as von Willebrand's disease or other bleeding disorders characterized by a deficiency or dysfunction of von Willebrand factor, desmopressin acetate can effectively enhance clotting by increasing the levels of this important factor in circulation. Consequently, this results in improved platelet function and reduced bleeding tendencies, which is vital in managing bleeding in animals.

The choice of option C emphasizes the mechanism through which desmopressin acetate achieves its therapeutic effect in managing bleeding disorders, highlighting its importance in veterinary medicine for treating cases with prolonged bleeding times.